Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine

E G Pedersen, Anton Pottegård, Jesper Hallas, S Friis, K Hansen, P E H Jensen, David Gaist

38 Citationer (Scopus)

Abstract

The association between use of azathioprine and risk of non-melanoma skin cancer (NMSC) in patients with myasthenia was evaluated in a nationwide setting. Treatment of autoimmune myasthenia frequently involves long-term exposure to immunosuppressants, including azathioprine. Use of azathioprine increases the risk of NMSC in organ recipients and probably also in patients with other autoimmune disorders. No previous study has specifically investigated the risk of NMSC in myasthenia patients treated with azathioprine.
OriginalsprogEngelsk
TidsskriftEuropean journal of neurology : the official journal of the European Federation of Neurological Societies
Vol/bind21
Udgave nummer3
Sider (fra-til)454-58
ISSN1351-5101
DOI
StatusUdgivet - 2014

Fingeraftryk

Dyk ned i forskningsemnerne om 'Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine'. Sammen danner de et unikt fingeraftryk.

Citationsformater